 | • レポートコード：MRC2-11QY04902 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結核診断・治療のグローバル市場について調査・分析したレポートです。種類別（臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査）市場規模、用途別（病院、政府機関、個人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結核診断・治療の競争状況、市場シェア ・世界の結核診断・治療市場：種類別市場規模 2015年-2020年（臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査） ・世界の結核診断・治療市場：種類別市場規模予測 2021年-2026年（臨床検査、核酸検査、マントー検査、X線撮影、薬剤感受性検査） ・世界の結核診断・治療市場：用途別市場規模 2015年-2020年（病院、政府機関、個人） ・世界の結核診断・治療市場：用途別市場規模予測 2021年-2026年（病院、政府機関、個人） ・北米の結核診断・治療市場分析：米国、カナダ ・ヨーロッパの結核診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結核診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結核診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結核診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Akonni Biosystems、Thermo Fisher Scientific、BD、Bio-Synth、bioMérieux、Cepheid、Eiken Chemical、Epistem、Roche、GSK、Hain Lifesciences、Hologic、Labatec、Lupin、Otsuka Novel Products、QIAGEN、Sandoz、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body.
The rising screening rate in the high burden regions, faster clinical decisions, and affordability of diagnostics, advanced methodologies, and reduction in mortality rate are the major areas of development.
Market Analysis and Insights: Global Tuberculosis Diagnosis and Treatment Market
The global Tuberculosis Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tuberculosis Diagnosis and Treatment Scope and Market Size
Tuberculosis Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Akonni Biosystems
Thermo Fisher Scientific
BD
Bio-Synth
bioMérieux
Cepheid
Eiken Chemical
Epistem
Roche
GSK
Hain Lifesciences
Hologic
Labatec
Lupin
Otsuka Novel Products
QIAGEN
Sandoz
Sanofi
Market segment by Type, the product can be split into
Laboratory testing
Nucleic acid tests
Mantoux test
Radiography
Drug susceptibility test
Market segment by Application, split into
Hospitals
Government organizations
Individual
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laboratory testing
1.4.3 Nucleic acid tests
1.4.4 Mantoux test
1.4.5 Radiography
1.4.6 Drug susceptibility test
1.5 Market by Application
1.5.1 Global Tuberculosis Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Government organizations
1.5.4 Individual
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Diagnosis and Treatment Growth Trends by Regions
2.2.1 Tuberculosis Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Diagnosis and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnosis and Treatment Revenue in 2019
3.3 Tuberculosis Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
6.2 Tuberculosis Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
7.2 Tuberculosis Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
8 China
8.1 China Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
8.2 Tuberculosis Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
9.2 Tuberculosis Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
10.2 Tuberculosis Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
11 India
11.1 India Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
11.2 Tuberculosis Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tuberculosis Diagnosis and Treatment Market Size (2015-2020)
12.2 Tuberculosis Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Akonni Biosystems
13.2.1 Akonni Biosystems Company Details
13.2.2 Akonni Biosystems Business Overview
13.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Introduction
13.2.4 Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.2.5 Akonni Biosystems Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview
13.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Introduction
13.3.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 BD
13.4.1 BD Company Details
13.4.2 BD Business Overview
13.4.3 BD Tuberculosis Diagnosis and Treatment Introduction
13.4.4 BD Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.4.5 BD Recent Development
13.5 Bio-Synth
13.5.1 Bio-Synth Company Details
13.5.2 Bio-Synth Business Overview
13.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Introduction
13.5.4 Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.5.5 Bio-Synth Recent Development
13.6 bioMérieux
13.6.1 bioMérieux Company Details
13.6.2 bioMérieux Business Overview
13.6.3 bioMérieux Tuberculosis Diagnosis and Treatment Introduction
13.6.4 bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.6.5 bioMérieux Recent Development
13.7 Cepheid
13.7.1 Cepheid Company Details
13.7.2 Cepheid Business Overview
13.7.3 Cepheid Tuberculosis Diagnosis and Treatment Introduction
13.7.4 Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.7.5 Cepheid Recent Development
13.8 Eiken Chemical
13.8.1 Eiken Chemical Company Details
13.8.2 Eiken Chemical Business Overview
13.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Introduction
13.8.4 Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.8.5 Eiken Chemical Recent Development
13.9 Epistem
13.9.1 Epistem Company Details
13.9.2 Epistem Business Overview
13.9.3 Epistem Tuberculosis Diagnosis and Treatment Introduction
13.9.4 Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.9.5 Epistem Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche Tuberculosis Diagnosis and Treatment Introduction
13.10.4 Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
13.10.5 Roche Recent Development
13.11 GSK
10.11.1 GSK Company Details
10.11.2 GSK Business Overview
10.11.3 GSK Tuberculosis Diagnosis and Treatment Introduction
10.11.4 GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.11.5 GSK Recent Development
13.12 Hain Lifesciences
10.12.1 Hain Lifesciences Company Details
10.12.2 Hain Lifesciences Business Overview
10.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Introduction
10.12.4 Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.12.5 Hain Lifesciences Recent Development
13.13 Hologic
10.13.1 Hologic Company Details
10.13.2 Hologic Business Overview
10.13.3 Hologic Tuberculosis Diagnosis and Treatment Introduction
10.13.4 Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.13.5 Hologic Recent Development
13.14 Labatec
10.14.1 Labatec Company Details
10.14.2 Labatec Business Overview
10.14.3 Labatec Tuberculosis Diagnosis and Treatment Introduction
10.14.4 Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.14.5 Labatec Recent Development
13.15 Lupin
10.15.1 Lupin Company Details
10.15.2 Lupin Business Overview
10.15.3 Lupin Tuberculosis Diagnosis and Treatment Introduction
10.15.4 Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.15.5 Lupin Recent Development
13.16 Otsuka Novel Products
10.16.1 Otsuka Novel Products Company Details
10.16.2 Otsuka Novel Products Business Overview
10.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Introduction
10.16.4 Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.16.5 Otsuka Novel Products Recent Development
13.17 QIAGEN
10.17.1 QIAGEN Company Details
10.17.2 QIAGEN Business Overview
10.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Introduction
10.17.4 QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.17.5 QIAGEN Recent Development
13.18 Sandoz
10.18.1 Sandoz Company Details
10.18.2 Sandoz Business Overview
10.18.3 Sandoz Tuberculosis Diagnosis and Treatment Introduction
10.18.4 Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.18.5 Sandoz Recent Development
13.19 Sanofi
10.19.1 Sanofi Company Details
10.19.2 Sanofi Business Overview
10.19.3 Sanofi Tuberculosis Diagnosis and Treatment Introduction
10.19.4 Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020)
10.19.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tuberculosis Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Tuberculosis Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Tuberculosis Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tuberculosis Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laboratory testing
Table 6. Key Players of Nucleic acid tests
Table 7. Key Players of Mantoux test
Table 8. Key Players of Radiography
Table 9. Key Players of Drug susceptibility test
Table 10. Global Tuberculosis Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Tuberculosis Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Tuberculosis Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 14. Global Tuberculosis Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Tuberculosis Diagnosis and Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Tuberculosis Diagnosis and Treatment Players
Table 21. Global Tuberculosis Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Tuberculosis Diagnosis and Treatment Market Share by Players (2015-2020)
Table 23. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2019)
Table 24. Global Tuberculosis Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Tuberculosis Diagnosis and Treatment Product Solution and Service
Table 27. Date of Enter into Tuberculosis Diagnosis and Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Tuberculosis Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 31. Global Tuberculosis Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Tuberculosis Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 33. Global Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Tuberculosis Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 37. North America Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 39. North America Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 43. Europe Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 45. Europe Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 49. China Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 51. China Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 55. Japan Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 57. Japan Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 61. Southeast Asia Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 67. India Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 69. India Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Tuberculosis Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Tuberculosis Diagnosis and Treatment Market Share (2019-2020)
Table 73. Central & South America Tuberculosis Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Tuberculosis Diagnosis and Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Tuberculosis Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Tuberculosis Diagnosis and Treatment Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Akonni Biosystems Company Details
Table 83. Akonni Biosystems Business Overview
Table 84. Akonni Biosystems Product
Table 85. Akonni Biosystems Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 86. Akonni Biosystems Recent Development
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Product
Table 90. Thermo Fisher Scientific Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 91. Thermo Fisher Scientific Recent Development
Table 92. BD Company Details
Table 93. BD Business Overview
Table 94. BD Product
Table 95. BD Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 96. BD Recent Development
Table 97. Bio-Synth Company Details
Table 98. Bio-Synth Business Overview
Table 99. Bio-Synth Product
Table 100. Bio-Synth Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 101. Bio-Synth Recent Development
Table 102. bioMérieux Company Details
Table 103. bioMérieux Business Overview
Table 104. bioMérieux Product
Table 105. bioMérieux Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 106. bioMérieux Recent Development
Table 107. Cepheid Company Details
Table 108. Cepheid Business Overview
Table 109. Cepheid Product
Table 110. Cepheid Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 111. Cepheid Recent Development
Table 112. Eiken Chemical Business Overview
Table 113. Eiken Chemical Product
Table 114. Eiken Chemical Company Details
Table 115. Eiken Chemical Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 116. Eiken Chemical Recent Development
Table 117. Epistem Company Details
Table 118. Epistem Business Overview
Table 119. Epistem Product
Table 120. Epistem Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 121. Epistem Recent Development
Table 122. Roche Company Details
Table 123. Roche Business Overview
Table 124. Roche Product
Table 125. Roche Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 126. Roche Recent Development
Table 127. GSK Company Details
Table 128. GSK Business Overview
Table 129. GSK Product
Table 130. GSK Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 131. GSK Recent Development
Table 132. Hain Lifesciences Company Details
Table 133. Hain Lifesciences Business Overview
Table 134. Hain Lifesciences Product
Table 135. Hain Lifesciences Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 136. Hain Lifesciences Recent Development
Table 137. Hologic Company Details
Table 138. Hologic Business Overview
Table 139. Hologic Product
Table 140. Hologic Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 141. Hologic Recent Development
Table 142. Labatec Company Details
Table 143. Labatec Business Overview
Table 144. Labatec Product
Table 145. Labatec Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 146. Labatec Recent Development
Table 147. Lupin Company Details
Table 148. Lupin Business Overview
Table 149. Lupin Product
Table 150. Lupin Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 151. Lupin Recent Development
Table 152. Otsuka Novel Products Company Details
Table 153. Otsuka Novel Products Business Overview
Table 154. Otsuka Novel Products Product
Table 155. Otsuka Novel Products Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 156. Otsuka Novel Products Recent Development
Table 157. QIAGEN Company Details
Table 158. QIAGEN Business Overview
Table 159. QIAGEN Product
Table 160. QIAGEN Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 161. QIAGEN Recent Development
Table 162. Sandoz Company Details
Table 163. Sandoz Business Overview
Table 164. Sandoz Product
Table 165. Sandoz Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 166. Sandoz Recent Development
Table 167. Sanofi Company Details
Table 168. Sanofi Business Overview
Table 169. Sanofi Product
Table 170. Sanofi Revenue in Tuberculosis Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 171. Sanofi Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Laboratory testing Features
Figure 3. Nucleic acid tests Features
Figure 4. Mantoux test Features
Figure 5. Radiography Features
Figure 6. Drug susceptibility test Features
Figure 7. Global Tuberculosis Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Government organizations Case Studies
Figure 10. Individual Case Studies
Figure 11. Tuberculosis Diagnosis and Treatment Report Years Considered
Figure 12. Global Tuberculosis Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Tuberculosis Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Tuberculosis Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Tuberculosis Diagnosis and Treatment Market Share by Players in 2019
Figure 17. Global Top Tuberculosis Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnosis and Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis Diagnosis and Treatment Revenue in 2019
Figure 19. North America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Tuberculosis Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
結核治療の世界市場（～2026年） Market Analysis and Insights: Global Tuberculosis Treatment Market The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tuberculosis Treatment Scope and Market Size Tuberculosis Treatment m…- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- 結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- クラミジア診断・治療の世界市場（～2026年） Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, The change in lifestyle especially related to sex preferences is the ma…